Are you a hipster, surfer or biker? What is your urban tribe? Your computer may soon be able to tell. Computer scientists at the University of California, San Diego, are developing an algorithm that uses group pictures to determine to which of these groups, or urban tribes, you belong. So far, the algorithm is 48 percent accurate on average. That’s better than chance—which gets answers right only nine percent of the time—but researchers would like the algorithm perform at least as well as humans would.
A team of scientists, led by Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine, has found that brain cancer cells resist therapy by dialing down the gene mutation targeted by drugs, then re-amplify that growth-promoting mutation after therapy has stopped.
Expanding their efforts to keep citizens safe on San Diego roadways, UC San Diego’s Training, Research and Education for Driving Safety (TREDS) program announced today that they are launching a new distracted driving education project called Just Drive - Take Action Against Distraction, a one hour class free of charge offered to businesses in San Diego.
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This “nanosponge vaccine” enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA—both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
Using quantitative models of bacterial growth, a team of UC San Diego biophysicists has discovered the bizarre way by which antibiotic resistance allows bacteria to multiply in the presence of antibiotics, a growing health problem in hospitals and nursing homes across the United States.
A key pillar of “the scientific method” is reproducibility, one way to prove another scientist’s experimental claims. If the experiment and its results can be reproduced, the validity of the work is considerably strengthened.
Using advanced methodologies that pit drug compounds against specific types of malaria parasite cells, an international team of scientists, including researchers at the University of California, San Diego School of Medicine and the Genomics Institute of the Novartis Research Foundation, have identified a potential new weapon and approach for attacking the parasites that cause malaria.
The University of California, San Diego will recognize World AIDS Day from 9 a.m. to 8 p.m. on Monday, Dec. 2 with a variety of free, public events, including a viewing of portions of the AIDS Memorial Quilt, the largest ongoing art project in the world. This year’s events reflect UC San Diego’s “Getting to Zero” theme which conveys the global community effort needed to achieve zero new HIV infections, zero stigma against those living with HIV/AIDS and zero AIDS-related deaths.
For the seventh consecutive year, the Training, Research and Education for Driving Safety program at the University of California, San Diego School of Medicine has been awarded a grant from the California Office of Traffic Safety that will help keep our roadways and senior drivers safe through professional training.
Researchers at the University of California, San Diego School of Medicine have successfully targeted T lymphocytes – which play a central role in the body’s immune response – with another type of white blood cell engineered to synthesize and deliver bits of non-coding RNA or microRNA (miRNA).